M1 Kliniken AG header image

M1 Kliniken AG

M12

Equity

ISIN DE000A0STSQ8 / Valor 29694419

Xetra (2025-11-21)
EUR 15.90-3.17%

M1 Kliniken AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

M1 Kliniken AG is a German-based company specializing in the provision of health services and medical treatments, particularly in the field of aesthetic medicine.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.11.2025):

M1 Kliniken AG reported strong financial results for the first half of 2025, demonstrating robust growth driven by enhanced efficiency and strategic expansion. The company achieved notable increases in revenue, EBIT, and earnings per share, underscoring its continued profitable trajectory in both its core Beauty segment and the broader Trading segment.

Financial Overview

For H1 2025, group revenue increased by 9.4% to EUR 183.5 million, while EBIT grew by 24% to EUR 18.0 million, improving the EBIT margin to 9.8%. Additionally, EBITDA rose by 21% and earnings per share climbed from EUR 0.53 to EUR 0.63 compared to H1 2024.

Beauty Segment Highlights

The Beauty segment, a key growth engine for M1 Kliniken AG, recorded a significant profitability surge with revenue up 5.5% reaching EUR 51.2 million and EBIT soaring by 48.9% to EUR 15.0 million. The marked improvement in EBIT margin to 29.4% reflects targeted pricing strategies and optimized operational processes.

Trading Segment Performance

Despite experiencing an 11% revenue increase to EUR 132.3 million for H1 2025, the Trading segment faced a decline in EBIT by 32.8%, resulting in a figure of EUR 2.9 million, indicating a mixed performance compared to the previous year's levels.

Outlook

Looking ahead, M1 Kliniken AG plans to continue its growth trajectory with both national and international clinic expansion, targeting substantial increases in the Beauty segment revenue for the full year 2025 and beyond, while aiming to maintain a sustainable EBIT margin of at least 20% by 2029.

Summarized from source with an LLMView Source

Key figures

-1.85%1Y
237%3Y
71.0%5Y

Performance

43.9%1Y
48.7%3Y
46.7%5Y

Volatility

Market cap

340 M

Market cap (USD)

Daily traded volume (Shares)

17,514

Daily traded volume (Shares)

1 day high/low

16.45 / 15.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.94%EUR 1.05
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.27%USD 21.18
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%EUR 26.60
Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.62%USD 101.12
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 13.91
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.45%CHF 67.10
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.66%EUR 18.44
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%DKK 580.20
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 5.03
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.79%SEK 260.90